Anthem Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	2,749	3,161	1,839	3,422	3,418
Short-Term Investments	6,656	-	-	4,929	2,691
Trading Asset Securities	-	4,161	4,591	-	-
Cash & Short-Term Investments	9,405	7,323	6,429	8,351	6,109
Cash Growth	28.43%	13.90%	-23.01%	36.70%	148.94%
Accounts Receivable	5,906	4,504	4,904	2,741	3,262
Other Receivables	-	95.15	1.96	12.15	73.23
Receivables	5,906	4,599	4,906	2,753	3,335
Inventory	1,245	3,404	2,113	1,294	582.3
Prepaid Expenses	-	2.14	31.67	19.43	25.04
Other Current Assets	1,476	2,039	1,335	814.18	881.44
Total Current Assets	18,031	17,367	14,816	13,232	10,933
Property, Plant & Equipment	10,471	9,981	8,210	6,039	4,759
Long-Term Investments	3,419	169.28	125.53	61.6	36.96
Other Intangible Assets	4.41	38.71	62.43	90.89	68.99
Long-Term Accounts Receivable	31.08	31.12	31.08	31.08	31.12
Long-Term Deferred Tax Assets	273.22	179.47	413.95	249.08	159.38
Other Long-Term Assets	1,990	253.87	249.73	370.15	127.81
Total Assets	34,293	28,076	23,981	20,145	16,189
Accounts Payable	752.17	1,101	1,007	719.41	648.41
Accrued Expenses	209.66	252.29	308.02	249.82	245.63
Short-Term Debt	-	429.53	817.96	87.46	274.93
Current Portion of Long-Term Debt	233.34	189.74	390.71	201.3	11.5
Current Portion of Leases	19.73	15.06	16.85	3.22	21.22
Current Income Taxes Payable	373.05	230.27	64.11	58.83	193.89
Current Unearned Revenue	-	-	-	3.85	-
Other Current Liabilities	1,669	1,045	781.21	314.81	866.29
Total Current Liabilities	3,257	3,262	3,386	1,639	2,262
Long-Term Debt	277.34	470.28	1,117	961.88	245.8
Long-Term Leases	8.83	28.56	43.06	7.64	24.39
Long-Term Unearned Revenue	7	9.35	11.69	14.18	16.64
Pension & Post-Retirement Benefits	-	43.87	39.78	33.6	31.99
Other Long-Term Liabilities	317.43	162.81	137.21	81.89	57.99
Total Liabilities	3,868	3,977	4,735	2,738	2,639
Common Stock	1,123	1,118	1,118	1,141	87.76
Additional Paid-In Capital	-	1,252	1,252	2,719	2,700
Retained Earnings	-	21,392	16,879	13,570	10,726
Comprehensive Income & Other	29,302	336.79	-2.72	-23.05	35.82
Shareholders' Equity	30,425	24,099	19,247	17,407	13,550
Total Liabilities & Equity	34,293	28,076	23,981	20,145	16,189
Total Debt	539.24	1,133	2,385	1,262	577.84
Net Cash (Debt)	8,865	6,190	4,044	7,090	5,531
Net Cash Growth	43.23%	53.05%	-42.96%	28.17%	286.71%
Net Cash Per Share	15.62	11.02	7.13	12.43	9.70
Filing Date Shares Outstanding	561.41	561.61	559.08	570.49	570.46
Total Common Shares Outstanding	561.41	559.08	559.08	570.49	570.46
Working Capital	14,774	14,105	11,429	11,593	8,671
Book Value Per Share	54.19	43.10	34.43	30.51	23.75
Tangible Book Value	30,421	24,060	19,184	17,316	13,481
Tangible Book Value Per Share	54.19	43.04	34.31	30.35	23.63
Land	-	836.13	836.13	836.13	836.13
Buildings	-	3,239	2,012	1,579	1,304
Machinery	-	8,595	6,761	6,137	4,632
Construction In Progress	-	2,969	3,447	1,641	1,538